Epicardial fat: Properties, function and relationship to obesity

Obesity Reviews

Volumn 8, Issue 3, 2007, Pages 253-261

  Rabkin, S W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Coronary atherosclerosis; Epicardial fat; Obesity

Indexed keywords

ACYL COENZYME A DESATURASE; ADIPOCYTOKINE; ADIPONECTIN; CD45 ANTIGEN; FATTY ACID; GLUCOCORTICOID; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOUNSATURATED FATTY ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL FAT; ADIPOSE TISSUE; BODY COMPOSITION; CARDIOVASCULAR DISEASE; CHEMICAL ANALYSIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CYTOKINE PRODUCTION; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EPICARDIUM FAT; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; GLUCOSE UTILIZATION; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART WEIGHT; HORMONE RELEASE; HUMAN; INFLAMMATORY CELL; INTRAABDOMINAL FAT; LIPID STORAGE; METABOLIC SYNDROME X; MICROCIRCULATION; OBESITY; PROTEIN CONTENT; REVIEW; SUBCUTANEOUS FAT; SURFACE PROPERTY; TISSUE DISTRIBUTION;

ADIPOSE TISSUE; AGE FACTORS; CORONARY THROMBOSIS; HEART; HUMANS; MYOCARDIUM; OBESITY; RISK FACTORS;

EID: 34247397526     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2006.00293.x     Document Type: Review

References (66)

1. Roy PE. Lipid droplets in the heart interstitium: concentration and distribution. Recent Adv Stud Cardiac Struct Metab 1975 10: 17 27.
2. Gabella G. Cardiovascular system. In: Gray's Anatomy 38th edn (Williams PL, ed Churchill Livingstone: Edinburgh, 1995, p. 1477.
3. Burke AP, Farb A, Tashko G, Virmani R. Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? Circulation 1998 97: 1571 1580.
4. Basso C, Thiene G. Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat? Cardiovasc Pathol 2005 4: 37 41.
5. Willis RA. The anatomic examination of the body of Thomas Parr. In: The Works of William Harvey. Sydenham Society: London, 1847, pp. 587 592.
6. Bedford The story of fatty heart. Disease of Victorian times. Brit Heart J 1972 34: 23 28.
7. Shirani J, Berezowski K, Roberts WC. Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am J Cardiol 1995 76: 414 418.
8. Smith HL, Willius FA. Adiposity of the heart. A clinical and pathologic study of one hundred and thirty size obese patients. Arch Intern Med 1933 52: 911 931.
9. Tansey DK, Aly Z, Sheppard MN. Fat in the right ventricle of the normal heart. Histopathology 2005 46: 98 104.
10. Reiner L, Mazzoleni A, Rodriguez FL. Statistical analysis of the epicardial fat weight in human hearts. AMA Arch Pathol 1955 60: 369 373.
11. Sons HU, Hoffmann V. Epicardial fat cell size, fat distribution and fat infiltration of the right and left ventricle of the heart. Anat Anzeiger 1986 161: 355 373.
12. Corradi D, Maestri R, Callegari S, Pastori P, Goldoni M, Luong TV, Bordi C. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol 2004 13: 313 316.
13. Roberts WC, Roberts JD. The floating heart or the heart too fat to sink: analysis of 55 necropsy patients. Am J Cardiol 1983 52: 1286 1289.
14. Schejbal V. Epicardial fatty tissue of the right ventricle - morphology, morphometry and functional significance. Pneumologie 1989 43: 490 499.
15. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, Leonetti F. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003 11: 304 310.
16. Schoenmackers J, Willmen HR. Uber lipomatosis cordis, ibre beziehungen zur leistungsfahigkeit und insuffozienz des rechten ventrikels. Arch Kreishaufforsch Darmstadt 1963 40: 251 283.
17. Reiner 1 Mazzoleni A, Rodriguez FL, Freundenthal RR. The weight of the human heart. I. Normal cases. AMA Arch Pathol 1959 68: 58 73.
18. Womack HC. The relationship between human body weight, subcutaneous fat, heart weight, and epicardial fat. Hum Biol 1983 55: 667 676.
19. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 2004 15: 1084 1087.
20. Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B Comp Biochem 1989 94: 225 232.
21. Keegan J, Gatehouse PD, Yang G-Z, Firmin DN. Spiral phase velocity mapping of left and right coronary aretery blood flow: correlation for through-plane motion using selective fat-only excitation. J Magnetic Resonanace Imaging 2004 20: 953 960.
22. Marchington JM, Pond CM. Site-specific properties of pericardial and epicardial adipose tissue. the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes 1990 14: 1013 1022.
23. Kong JY, Rabkin SW. Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin. Biochim Biophys Acta 2000 1485: 1 11.
24. Kong JY, Rabkin SW. Cardiac apoptosis induced by palmitate is mediated through carnitine palmitoyl transferase 1. Am J Physiol (Heart Circulation) 2002 282: H717 H725.
25. Pond CM, Mattacks CA, Calder PC, Evans J. Site-specific properties of human adipose depots homologous to those of other mammals. Comp Biochem Physiol Comp Physiol 1993 104: 819 824.
26. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987 316: 1371 1375.
27. Ward MR, Jeremias A, Hibi K, Herity NA, Lo ST, Filardo SD, Lee DP, Fitzgerald PJ, Yeung AC. The influence of plaque orientation (pericardial or myocardial) on coronary arterial remodeling. Atherosclerosis 2001 154: 179 183.
28. Prati F, Arbustini E, Labellarte A, Sommariva L, Pawlowski T, Manzoli A, Pagano A, Motolese M, Boccanelli A. Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: a permissive role of epicardial fat? A three-dimensional intravascular ultrasound study of left anterior descending artery lesions. Eur Heart J 2003 24: 329 336.
29. Arora RC, Waldmann M, Hopkins DA, Armour JA. Porcine intrinsic cardiac ganglia. Anat Rec A Discov Mol Cell Evol Biol 2003 271: 249 258.
30. Huang MH, Ardell JL, Hanna BD, Wolf SG, Armour JA. Effects of transient coronary artery occlusion on canine intrinsic cardiac neuronal activity. Integr Physiol Behav Sci 1993 28: 5 21.
31. Sylven C. Mechanisms of pain in angina pectoris - a critical review of the adenosine hypothesis. Cardiovasc Drugs Ther 1993 7: 745 759.
32. House AA, Walley VM. Right heart failure due to ventricular adiposity: 'adipositas cordis' - an old diagnosis revisited. Can J Cardiol 1996 12: 485 489.
33. Dietze D, Koenen M, Rohrig K, Horikoshi H, Hausne H, Eckel J. Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 2002 51: 2369 2376.
34. Barber MC, Ward RJ, Richards SE, Salter AM, Buttery PJ, Vernon RG, Travers MT. Ovine adipose tissue monounsaturated fat content is correlated to depot-specific expression of the stearoyl-CoA desaturase gene. J Anim Sci 2000 78: 62 68.
35. Rabkin SW, Mathewson FAL, Hsu PH. Relationship of body weight to incidence of ischemic heart disease in a cohort of North American men followed for twenty-six years. Manitoba Study. Am J Cardiol 1977 39: 452 458.
36. Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, Di Mario U, Leonetti F. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003 88: 5163 5168.
37. Muller W. de Massenverhaltnisse des menschlichen herzens. Hamburg und Leipzig: Verlag Von Leopold Vos, 1883.
38. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285: 2486 2497.
39. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998 15: 539 553.
40. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005 365: 1415 1428.
41. Vinicor F, Bowman B. The metabolic syndrome: the emperor needs some consistent clothes. Diabetes Care 2004 27: 1243.
42. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2005 48: 1684 1699.
43. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001 24: 683 689.
44. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002 288: 2709 2716.
45. Wajchenberg BL, Giannella-Neto D, da Silva MER, Santos RF. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 2002 34: 616 621.
46. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, Teboul M, Massiera F, Sharma AM. The adipose-tissue renin-angiotensin- aldosterone system. role in the metabolic syndrome? Int J Biochem Cell Biol 2003 35: 807 825.
47. Skurk T, Hauner H. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Int J Obes Relat Metab Disord 2004 28: 1357 1364.
48. Goodarzi MO, Guo X, Taylor KD, Quinones MJ, Saad MF, Yang H, Hsueh WA, Rotter JI. Lipoprotein lipase is a gene for insulin resistance in Mexican Americans. Diabetes 2004 53: 214 220.
49. Holzl B, Iglseder B, Sandhofer A, Malaimare L, Lang J, Paulweber B, Sandhofer F. Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency. Diabetologia 2002 45: 378 384.
50. Kitajima S, Morimoto M, Liu E, Koike T, Higaki Y, Taura Y, Mamba K, Itamoto K, Watanabe T, Tsutsumi K, Yamada N, Fan J. Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits. Diabetologia 2004 47: 1202 1209.
51. Koike T, Liang J, Wang X, Ichikawa T, Shiomi M, Liu G, Sun H, Kitajima S, Morimoto M, Watanabe T, Yamada N, Fan J. Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity. J Biol Chem 2004 279: 7521 7529.
52. Ntambi JM, Miyazaki M. Recent insights into stearoyl-CoA desaturase-1. Curr Opin Lipidol 2003 14: 255 261.
53. Biddinger SB, Almind K, Miyazaki M, Kokkotou E, Ntambi JM, Kahn CR. Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. Diabetes 2005 54: 1314 1323.
54. Tong L. Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery. Cell Mol Life Sci 2005 62: 1784 1803.
55. World Health Organization. Obesity, Preventing and Managing the Global Epidemic. Report of a WHO Consultancy on Obesity. WHO: Geneva, 1997.
56. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, Narayan KM, Williamson DF. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005 293: 1868 1874.
57. Sundell J. Obesity and diabetes as risk factors for coronary artery disease: from the epidemiological aspect to the initial vascular mechanisms. Diabetes Obes Metab 2005 7: 9 20.
58. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O'Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003 108: 2460 2466.
59. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005 352: 1685 1695.
60. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J 2002 16: 1057 1063.
61. Baker AR, da Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, Kumar S, McTernana PG. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular diseases. Cardiovasc Diabetol 2006 5: 1 7.
62. Laine P, Kaartinen M, Penttila A, Panula P, Paavonen T, Kovanen PT. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 1999 99: 361 369.
63. Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol 2005 46: 1978 1985.
64. Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, Gallo P, di Gioia CR. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005 29: 251 255.
65. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 2005 126: 121 129.
66. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005 288: H2031 H2041.